Autologous and Allogeneic Cellular Therapies for High-risk Pediatric Solid Tumors
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in Pediatric Clinics of North America
- Vol. 57 (1), 47-66
- https://doi.org/10.1016/j.pcl.2010.01.001
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Full Response of a Localized Renal Tumour after Reduced-Intensity Conditioned Hematopoietic Stem Cell TransplantationCase Reports in Medicine, 2009
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaNature Medicine, 2008
- Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- Adoptive T cell therapy for cancer in the clinicJCI Insight, 2007
- Principles of adoptive T cell cancer therapyJCI Insight, 2007
- Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsBlood, 2006
- 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusionsEuropean Journal of Cancer, 1997
- Recent advances in the treatment of Hodgkinʼs diseaseCurrent Opinion in Hematology, 1997
- Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group resultsEuropean Journal of Cancer, 1995
- Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastomaEuropean Journal of Cancer, 1995